Serum Institute of India, Ltd. in Stake Sale Talks at $12 Billion Valuation
Indian billionaire Cyrus Poonawalla is in talks with private equity firms and sovereign funds about selling as much as a 10 percent stake in Asia’s largest vaccine maker, Serum Institute of India Ltd.
Serum is seeking a valuation of as much as 800 billion rupees ($12 billion), Chief Executive Officer Adar Poonawalla said. The company is in discussions with funds from Singapore and the U.S. about the sale of a 5 to 10 percent stake, he said in a Sept. 16 interview at Serum’s headquarters in the western Indian city of Pune.
Help employers find you! Check out all the jobs and post your resume.
Serum is seeking a valuation of as much as 800 billion rupees ($12 billion), Chief Executive Officer Adar Poonawalla said. The company is in discussions with funds from Singapore and the U.S. about the sale of a 5 to 10 percent stake, he said in a Sept. 16 interview at Serum’s headquarters in the western Indian city of Pune.
Help employers find you! Check out all the jobs and post your resume.